
Neurodegenerative diseases are difficult to detect and track through visual assessment alone, often remaining hidden until a patient’s health has already declined. But what if AI-powered imaging could change that? Supported by real-world research, this article explores how standardised, automated, objective tools like Neuro Suite are making neurodegenerative diseases more visible, measurable and actionable through longitudinal tracking, providing consistency and helping to improve the care pathway.
By enabling earlier intervention and more coordinated care, these innovations could transform both patient and clinical experiences. Discover how AI is helping clinicians work more efficiently within a unified platform, and why this shift could redefine brain health worldwide.
© 2025, Lyonsdown Limited. Business Reporter® is a registered trademark of Lyonsdown Ltd. VAT registration number: 830519543